The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE), ZOETIS (NYSE:ZTS), Boston Scientific Corp (NYSE:BSX), Humana (NYSE:HUM).
The investment seeks long-term capital appreciation.
The fund invests at least 80% of its assets in the equity securities of health care-related companies worldwide as selected by the sub-adviser. It will invest in securities of issuers located in a number of different countries throughout the world, one of which may be the United States; however, it has no limit on the amount of assets that may be invested in each country. The fund may invest in securities of companies of any market capitalization.
The average market capitalization across the Hartford Healthcare HLS IA MF is 153.83B. The market cap for tickers in the group ranges from 62.87B to 561.54B. LLY holds the highest valuation in this group at 561.54B. The lowest valued company is HUM at 62.87B.
The average weekly volume growth across all stocks in the Hartford Healthcare HLS IA MF was -5%. For the same stocks of the MF, the average monthly volume growth was -22% and the average quarterly volume growth was 17%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 46
P/E Growth Rating: 54
Price Growth Rating: 49
SMR Rating: 57
Profit Risk Rating: 38
Seasonality Score: 25 (-100 ... +100)